Compare UEIC & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UEIC | KZR |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 29.7M |
| IPO Year | 1993 | 2018 |
| Metric | UEIC | KZR |
|---|---|---|
| Price | $3.23 | $6.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $9.25 | $6.00 |
| AVG Volume (30 Days) | ★ 148.9K | 42.8K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $390,997,000.00 | N/A |
| Revenue This Year | $0.57 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.35 | N/A |
| 52 Week Low | $2.69 | $3.53 |
| 52 Week High | $12.50 | $7.60 |
| Indicator | UEIC | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 64.60 |
| Support Level | $3.06 | $6.05 |
| Resistance Level | $3.36 | $6.29 |
| Average True Range (ATR) | 0.19 | 0.14 |
| MACD | 0.08 | -0.06 |
| Stochastic Oscillator | 75.70 | 60.00 |
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.